UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura

Turkish journal of haematology, 2016-06, Vol.33 (2), p.153-155

2016

Volltextzugriff (PDF)

CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients

Medical oncology (Northwood, London, England), 2010-03, Vol.27 (1), p.29-33

2010

Volltextzugriff (PDF)

Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia

Prenatal diagnosis, 2008-11, Vol.28 (11), p.1052-1056

2008

Volltextzugriff (PDF)

Inflammation and Hypercoagulable State in Adult Psoriatic Men

Acta dermato-venereologica, 2008-01, Vol.88 (4), p.337-340

2008

Volltextzugriff (PDF)

Sticky platelet syndrome in patients with uninduced venous thrombosis

Turkish journal of haematology, 2013-03, Vol.30 (1), p.48-52

2013

Volltextzugriff (PDF)

Could mean platelet volume be a predictive marker for gestational diabetes mellitus?

Hematology (Luxembourg), 2008-02, Vol.13 (1), p.46-48

2008

Volltextzugriff (PDF)

Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma

Blood, 2023-06, Vol.141 (22), p.2780-2783

2023

Volltextzugriff (PDF)

Response-adapted therapy (tx) with nivolumab plus brentuximab vedotin (nivo + BV) without autologous hematopoietic cell transplantation (auto-HCT) in children, adolescents, and young adults (CAYA) with low-risk relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL): CheckMate 744

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7515-7515

2023

Volltextzugriff (PDF)

Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy

Blood, 2024-02, Vol.143 (9), p.786

2024

Volltextzugriff (PDF)

Mean platelet volume increase after tamoxifen, but not after anastrazole in adjuvant therapy of breast cancer

Medical oncology (Northwood, London, England), 2010-06, Vol.27 (2), p.199-202

2010

Volltextzugriff (PDF)

The Efficacy of Helicobacter pylori Eradication in the Treatment of Idiopathic Thrombocytopenic Purpura – The First Study in Turkey

Acta haematologica, 2006-01, Vol.116 (2), p.146-149

2006

Volltextzugriff (PDF)

Platelet indices in patients with colorectal cancer

Central European journal of medicine, 2010-06, Vol.5 (3), p.365-368

2010

Volltextzugriff (PDF)

Rapid Normalization of a Highly Thickened Pericardium by Chemotherapy in a Patient with T‐cell Acute Lymphoblastic Lymphoma

Clinical cardiology (Mahwah, N.J.), 2009-06, Vol.32 (6), p.E51-E53

2009

Volltextzugriff (PDF)

Abstract 5222: Biomarkers associated with complete metabolic response (CMR) to nivolumab and brentuximab vedotin (nivo + BV) for the treatment of children, adolescents, and young adults (CAYA) with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) in the CheckMate 744 study

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5222-5222

2022

Volltextzugriff (PDF)

Primary breast lymphoma treated with r-chop chemotherapy

Electronic journal of general medicine, 2009-07, Vol.6 (3), p.187-188

2009

Volltextzugriff (PDF)

The Diagnosis of Non Hodgkin Lymphoma in an Epidermodysplasia Verruciformis Patient

Electronic journal of general medicine, 2009-04, Vol.6 (2), p.136-138

2009

Volltextzugriff (PDF)

Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura/Idiyopatik Trombositopenik Purpura Olgularinda Düzenleyici T Hücreler

Turkish journal of haematology, 2016-06, Vol.33 (2), p.153

2016

Volltextzugriff (PDF)

Peripheral blood CD4+CRTH2+ cells in advanced stage non small cell lung cancer

Central European journal of medicine, 2010-08, Vol.5 (4), p.431-436

2010

Volltextzugriff (PDF)

Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study

Blood advances, 2023-10, Vol.7 (20), p.6266-6274

2023

Volltextzugriff (PDF)

Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up

Blood advances, 2023-09, Vol.7 (18), p.5272-5280

2023

Volltextzugriff (PDF)

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Blood advances, 2024-05, Vol.8 (10), p.2400-2404

2024

Volltextzugriff (PDF)

Results of treatment of acute myeloid leukemia and myelodysplastic syndrome with etoposide, thioguanine, cytarabine (ETC) in elderly patients

Turkish journal of haematology, 2006-12, Vol.23 (4), p.193-196

2006

Volltextzugriff (PDF)

The effect of subclinical hypothyroidism on platelet parameters

Hematology (Luxembourg), 2009-04, Vol.14 (2), p.115-117

2009

Volltextzugriff (PDF)

HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?

Hematology (Luxembourg), 2009-04, Vol.14 (2), p.101-105

2009

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(46)

Sprache

Englisch
(42)
Türkisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(25)
Hematology
(19)
Female
(15)
Male
(14)
Adult
(13)
Middle Aged
(10)
Aged
(8)
Internal Medicine
(6)
Case-Control Studies
(5)
Mean Platelet Volume
(5)
Medicine
(5)
Medicine & Public Health
(5)
Platelet Count
(5)
Retrospective Studies
(5)
Aged, 80 And Over
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Biological And Medical Sciences
(4)
General & Internal Medicine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura

CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients

Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia

Inflammation and Hypercoagulable State in Adult Psoriatic Men

Sticky platelet syndrome in patients with uninduced venous thrombosis

Could mean platelet volume be a predictive marker for gestational diabetes mellitus?

Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma

Response-adapted therapy (tx) with nivolumab plus brentuximab vedotin (nivo + BV) without autologous hematopoietic cell transplantation (auto-HCT) in children, adolescents, and young adults (CAYA) with low-risk relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL): CheckMate 744

Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy

Mean platelet volume increase after tamoxifen, but not after anastrazole in adjuvant therapy of breast cancer

The Efficacy of Helicobacter pylori Eradication in the Treatment of Idiopathic Thrombocytopenic Purpura – The First Study in Turkey

Platelet indices in patients with colorectal cancer

Rapid Normalization of a Highly Thickened Pericardium by Chemotherapy in a Patient with T‐cell Acute Lymphoblastic Lymphoma

Abstract 5222: Biomarkers associated with complete metabolic response (CMR) to nivolumab and brentuximab vedotin (nivo + BV) for the treatment of children, adolescents, and young adults (CAYA) with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) in the CheckMate 744 study

Primary breast lymphoma treated with r-chop chemotherapy

The Diagnosis of Non Hodgkin Lymphoma in an Epidermodysplasia Verruciformis Patient

Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura/Idiyopatik Trombositopenik Purpura Olgularinda Düzenleyici T Hücreler

Peripheral blood CD4+CRTH2+ cells in advanced stage non small cell lung cancer

Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study

Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Results of treatment of acute myeloid leukemia and myelodysplastic syndrome with etoposide, thioguanine, cytarabine (ETC) in elderly patients

The effect of subclinical hypothyroidism on platelet parameters

HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?

Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)

Suchergebnisse filtern